Related Experiment Video
Updated: Aug 14, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern
Annie O Chan1, Amr S Soliman, Qing Zhang
1Department of Pathology, Division of Pathology and Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Summary
Colorectal cancer molecular profiles vary significantly across Middle Eastern countries, indicating distinct disease origins. These differences impact patient management and clinical trial applicability.
Area of Science:
- Oncology
- Molecular Pathology
- Genetics
Background:
- Colorectal carcinoma (CRC) epidemiology varies globally.
- Molecular characteristics of CRC are often assumed to be uniform across populations.
- International variations in CRC molecular pathology are understudied but crucial for patient management.
Purpose of the Study:
- To investigate international differences in molecular pathology of colorectal carcinoma.
- To compare gene methylation patterns and mutation frequencies in CRC from Egypt, Jordan, and Turkey.
Main Methods:
- Analysis of CpG island methylator phenotype pathway, microsatellite instability pathway, and K-ras/p53 gene status.
- Study included 247 colorectal carcinomas from Egypt, Jordan, and Turkey.
Main Results:
- Egyptian CRC showed the lowest methylation frequencies.
- Jordanian CRC had increased methylation of the p16 tumor suppressor gene and MINT31 locus.
- Turkish CRC exhibited higher K-ras mutations and p53 overexpression, similar to Western cases.
Conclusions:
- Colorectal carcinomas from Middle Eastern countries display distinct molecular profiles.
- These variations suggest different environmental exposures influencing CRC pathogenesis.
- Disparities in molecular characteristics may affect prevention, treatment efficacy, and clinical trial outcomes.
Related Concept Videos
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...